A clinical study at Xinjiang Bazhou People’s Hospital Emergency Centre proved yet again the unquestionable efficiency of the Clearmate by Thornhill Medical.

The study was aimed at investigating the therapeutic efficiency of this medical device for acute monoxide poisoning and eventual delayed neuropsyconeural sequela. Between April 2010 and April 2014, 60 patients were treated for carbon monoxide poisoning using the Clearmate and a control group of 60 others received conventional treatment. The test group’s therapeutic efficiency was 96.67% compared to 60% for the control group. As for the incidences of delayed neuropsychoneural sequela, 3.33% of the test group was affected compared to 30% for the control group. You can read all the details of this clinical study by clicking here. If you want to learn more about the Clearmate, please contact us.

Leave your comments


  • No comments found